Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Linkage Disequilibrium | 7 | 2019 | 1996 | 1.360 |
Why?
|
Genome-Wide Association Study | 26 | 2024 | 12806 | 1.100 |
Why?
|
Asthma | 9 | 2024 | 6268 | 0.930 |
Why?
|
Polymorphism, Single Nucleotide | 24 | 2024 | 16044 | 0.880 |
Why?
|
Models, Genetic | 8 | 2024 | 3450 | 0.810 |
Why?
|
Genetic Association Studies | 5 | 2020 | 2746 | 0.730 |
Why?
|
DNA Methylation | 2 | 2024 | 4427 | 0.660 |
Why?
|
Computer Simulation | 8 | 2023 | 6259 | 0.550 |
Why?
|
Genetic Predisposition to Disease | 22 | 2024 | 18075 | 0.540 |
Why?
|
Nuclear Family | 1 | 2017 | 311 | 0.540 |
Why?
|
Biostatistics | 1 | 2018 | 162 | 0.540 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2024 | 3796 | 0.520 |
Why?
|
Genome | 5 | 2024 | 1752 | 0.490 |
Why?
|
Air Pollution, Indoor | 1 | 2020 | 931 | 0.410 |
Why?
|
Haplotypes | 1 | 2017 | 2727 | 0.370 |
Why?
|
Recombination, Genetic | 1 | 2015 | 1525 | 0.360 |
Why?
|
Epigenesis, Genetic | 1 | 2023 | 3824 | 0.340 |
Why?
|
Genetic Loci | 4 | 2024 | 2630 | 0.330 |
Why?
|
Apolipoproteins E | 4 | 2024 | 1459 | 0.320 |
Why?
|
Multifactorial Inheritance | 4 | 2024 | 1425 | 0.310 |
Why?
|
Alzheimer Disease | 7 | 2024 | 8717 | 0.290 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 5 | 2024 | 3246 | 0.290 |
Why?
|
Phenotype | 7 | 2022 | 16724 | 0.280 |
Why?
|
Genome, Human | 2 | 2019 | 4443 | 0.270 |
Why?
|
Bipolar Disorder | 6 | 2020 | 5130 | 0.230 |
Why?
|
Genomics | 7 | 2024 | 5923 | 0.220 |
Why?
|
DNA Probes | 1 | 2024 | 541 | 0.220 |
Why?
|
Models, Statistical | 1 | 2018 | 5091 | 0.220 |
Why?
|
Algorithms | 5 | 2024 | 14072 | 0.200 |
Why?
|
Dystrophin-Associated Proteins | 1 | 2022 | 60 | 0.200 |
Why?
|
Interferon Regulatory Factors | 2 | 2019 | 272 | 0.180 |
Why?
|
Pliability | 1 | 2019 | 57 | 0.170 |
Why?
|
Family | 3 | 2020 | 3209 | 0.170 |
Why?
|
Quantitative Trait Loci | 2 | 2019 | 2136 | 0.170 |
Why?
|
RGS Proteins | 1 | 2020 | 76 | 0.170 |
Why?
|
CpG Islands | 1 | 2024 | 1208 | 0.170 |
Why?
|
Hypersensitivity, Immediate | 1 | 2023 | 348 | 0.170 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2019 | 120 | 0.170 |
Why?
|
Gene Frequency | 4 | 2023 | 3624 | 0.170 |
Why?
|
Humans | 45 | 2024 | 766766 | 0.160 |
Why?
|
Complement C1 Inhibitor Protein | 1 | 2018 | 97 | 0.150 |
Why?
|
Forced Expiratory Volume | 2 | 2022 | 1828 | 0.150 |
Why?
|
Fungi | 1 | 2020 | 346 | 0.150 |
Why?
|
Epigenomics | 1 | 2023 | 959 | 0.140 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2023 | 520 | 0.140 |
Why?
|
Regression Analysis | 2 | 2018 | 6329 | 0.140 |
Why?
|
Cluster Analysis | 3 | 2022 | 2717 | 0.140 |
Why?
|
Choline Dehydrogenase | 1 | 2016 | 4 | 0.140 |
Why?
|
Pedigree | 3 | 2020 | 4539 | 0.140 |
Why?
|
Fibroblast Growth Factors | 1 | 2023 | 871 | 0.140 |
Why?
|
Vital Capacity | 1 | 2019 | 995 | 0.130 |
Why?
|
Panic Disorder | 1 | 2019 | 613 | 0.130 |
Why?
|
Neuropeptides | 1 | 2022 | 950 | 0.130 |
Why?
|
Genetic Linkage | 2 | 2019 | 2342 | 0.130 |
Why?
|
Barrett Esophagus | 1 | 2019 | 494 | 0.130 |
Why?
|
LDL-Receptor Related Proteins | 1 | 2015 | 118 | 0.120 |
Why?
|
Adrenal Cortex Hormones | 1 | 2024 | 1885 | 0.120 |
Why?
|
Population | 1 | 2015 | 140 | 0.120 |
Why?
|
Genetics, Population | 2 | 2019 | 943 | 0.120 |
Why?
|
Metabolomics | 1 | 2024 | 1675 | 0.120 |
Why?
|
Probability | 1 | 2019 | 2476 | 0.110 |
Why?
|
Confidence Intervals | 1 | 2019 | 2921 | 0.110 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2024 | 2902 | 0.110 |
Why?
|
Cell Adhesion Molecules | 1 | 2019 | 1612 | 0.110 |
Why?
|
Databases, Genetic | 1 | 2020 | 1756 | 0.100 |
Why?
|
Proportional Hazards Models | 2 | 2024 | 12534 | 0.100 |
Why?
|
Alopecia | 1 | 2017 | 416 | 0.100 |
Why?
|
Mood Disorders | 1 | 2017 | 1127 | 0.090 |
Why?
|
Depressive Disorder, Major | 2 | 2019 | 4810 | 0.090 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1751 | 0.080 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2020 | 2885 | 0.080 |
Why?
|
Esophageal Neoplasms | 1 | 2019 | 1660 | 0.080 |
Why?
|
Signal Transduction | 3 | 2024 | 23619 | 0.080 |
Why?
|
Smoking | 2 | 2024 | 9077 | 0.080 |
Why?
|
Female | 19 | 2024 | 396520 | 0.080 |
Why?
|
Male | 18 | 2024 | 364142 | 0.070 |
Why?
|
Software | 2 | 2019 | 4466 | 0.070 |
Why?
|
Germany | 2 | 2020 | 882 | 0.070 |
Why?
|
Data Interpretation, Statistical | 1 | 2017 | 2693 | 0.070 |
Why?
|
MicroRNAs | 1 | 2023 | 3792 | 0.070 |
Why?
|
Depression | 2 | 2024 | 8228 | 0.070 |
Why?
|
Child | 7 | 2024 | 80668 | 0.070 |
Why?
|
Reproducibility of Results | 1 | 2024 | 20144 | 0.070 |
Why?
|
Body Mass Index | 2 | 2021 | 13050 | 0.060 |
Why?
|
Sequence Analysis, DNA | 1 | 2017 | 4780 | 0.060 |
Why?
|
Environmental Exposure | 1 | 2020 | 4554 | 0.060 |
Why?
|
Parents | 1 | 2019 | 3593 | 0.060 |
Why?
|
Apolipoprotein C-I | 1 | 2024 | 14 | 0.060 |
Why?
|
Disease-Free Survival | 2 | 2024 | 6850 | 0.060 |
Why?
|
Sex Factors | 3 | 2024 | 10619 | 0.050 |
Why?
|
Chemokines, CXC | 1 | 2024 | 420 | 0.050 |
Why?
|
Mucin-5B | 1 | 2023 | 148 | 0.050 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2024 | 564 | 0.050 |
Why?
|
Dithionitrobenzoic Acid | 1 | 2022 | 22 | 0.050 |
Why?
|
Drug Repositioning | 1 | 2024 | 246 | 0.050 |
Why?
|
Risk | 3 | 2020 | 9602 | 0.050 |
Why?
|
Adrenal Insufficiency | 1 | 2024 | 194 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2019 | 6359 | 0.050 |
Why?
|
Adrenal Glands | 1 | 2024 | 556 | 0.050 |
Why?
|
Administration, Inhalation | 1 | 2024 | 1154 | 0.050 |
Why?
|
Schizophrenia | 2 | 2017 | 6976 | 0.050 |
Why?
|
Risk Factors | 6 | 2024 | 74881 | 0.050 |
Why?
|
Psychotic Disorders | 1 | 2015 | 3276 | 0.040 |
Why?
|
Neutralization Tests | 1 | 2022 | 735 | 0.040 |
Why?
|
Bronchi | 1 | 2024 | 847 | 0.040 |
Why?
|
Estonia | 1 | 2019 | 56 | 0.040 |
Why?
|
Metalloproteases | 1 | 2020 | 60 | 0.040 |
Why?
|
Principal Component Analysis | 1 | 2023 | 949 | 0.040 |
Why?
|
Costa Rica | 1 | 2019 | 187 | 0.040 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2024 | 366 | 0.040 |
Why?
|
Cuba | 1 | 2018 | 48 | 0.040 |
Why?
|
Spirometry | 1 | 2022 | 929 | 0.040 |
Why?
|
Time Factors | 2 | 2017 | 40149 | 0.040 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2019 | 191 | 0.040 |
Why?
|
Viral Envelope Proteins | 1 | 2022 | 640 | 0.040 |
Why?
|
Waist-Hip Ratio | 1 | 2019 | 521 | 0.040 |
Why?
|
Membrane Transport Proteins | 1 | 2024 | 1029 | 0.040 |
Why?
|
Mental Disorders | 1 | 2018 | 6869 | 0.040 |
Why?
|
Aged | 7 | 2024 | 171343 | 0.040 |
Why?
|
Alleles | 2 | 2020 | 6895 | 0.040 |
Why?
|
Eosinophils | 1 | 2023 | 952 | 0.040 |
Why?
|
Zinc Fingers | 1 | 2020 | 577 | 0.040 |
Why?
|
Genotype | 3 | 2017 | 13036 | 0.040 |
Why?
|
Fibroblast Growth Factor 5 | 1 | 2017 | 9 | 0.040 |
Why?
|
Age of Onset | 1 | 2024 | 3342 | 0.040 |
Why?
|
Denmark | 1 | 2019 | 777 | 0.030 |
Why?
|
Obesity | 1 | 2019 | 13090 | 0.030 |
Why?
|
Metabolome | 1 | 2024 | 1009 | 0.030 |
Why?
|
Brazil | 1 | 2021 | 1249 | 0.030 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2022 | 621 | 0.030 |
Why?
|
3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2017 | 74 | 0.030 |
Why?
|
Penetrance | 1 | 2018 | 388 | 0.030 |
Why?
|
ROC Curve | 1 | 2024 | 3620 | 0.030 |
Why?
|
Sweden | 1 | 2019 | 1382 | 0.030 |
Why?
|
Immunoglobulin E | 1 | 2023 | 1495 | 0.030 |
Why?
|
Benchmarking | 1 | 2023 | 1056 | 0.030 |
Why?
|
Hydrocortisone | 1 | 2024 | 1838 | 0.030 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2016 | 322 | 0.030 |
Why?
|
Lung | 2 | 2024 | 10067 | 0.030 |
Why?
|
Child, Preschool | 3 | 2024 | 42577 | 0.030 |
Why?
|
Gene Expression Profiling | 2 | 2024 | 9525 | 0.030 |
Why?
|
Meta-Analysis as Topic | 1 | 2019 | 1365 | 0.030 |
Why?
|
Adipogenesis | 1 | 2017 | 370 | 0.030 |
Why?
|
Linear Models | 1 | 2024 | 5874 | 0.030 |
Why?
|
Chromosomes, Human | 1 | 2015 | 437 | 0.030 |
Why?
|
Phylogeny | 1 | 2021 | 2840 | 0.030 |
Why?
|
Dyspnea | 1 | 2021 | 1352 | 0.030 |
Why?
|
Pneumonia | 1 | 2024 | 2159 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2024 | 3691 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2024 | 3601 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2022 | 2801 | 0.020 |
Why?
|
Base Sequence | 1 | 2022 | 12415 | 0.020 |
Why?
|
Cohort Studies | 2 | 2024 | 41710 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2024 | 9547 | 0.020 |
Why?
|
Melatonin | 1 | 2017 | 670 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2022 | 3702 | 0.020 |
Why?
|
Proteomics | 1 | 2024 | 3914 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2022 | 3212 | 0.020 |
Why?
|
Middle Aged | 5 | 2024 | 223257 | 0.020 |
Why?
|
Cell Line | 1 | 2024 | 15563 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2017 | 1657 | 0.020 |
Why?
|
Adolescent | 3 | 2024 | 88904 | 0.020 |
Why?
|
Fetus | 1 | 2015 | 1878 | 0.020 |
Why?
|
Risk Assessment | 2 | 2019 | 24295 | 0.020 |
Why?
|
Trans-Activators | 1 | 2017 | 2855 | 0.020 |
Why?
|
Databases, Factual | 1 | 2022 | 8066 | 0.020 |
Why?
|
Gene Expression | 1 | 2018 | 7585 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2019 | 59550 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9661 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 3666 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14762 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13640 | 0.010 |
Why?
|
Prognosis | 1 | 2023 | 29948 | 0.010 |
Why?
|
Pregnancy | 1 | 2023 | 30237 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2015 | 12791 | 0.010 |
Why?
|
Genetic Variation | 1 | 2015 | 6612 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2017 | 7868 | 0.010 |
Why?
|
Brain | 2 | 2016 | 27159 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2017 | 22248 | 0.010 |
Why?
|
Animals | 2 | 2024 | 168930 | 0.010 |
Why?
|
Mice | 1 | 2024 | 81889 | 0.010 |
Why?
|
Mutation | 1 | 2021 | 30213 | 0.010 |
Why?
|
Adult | 2 | 2019 | 223307 | 0.010 |
Why?
|
Young Adult | 1 | 2019 | 59939 | 0.010 |
Why?
|
Concepts
(184)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(56)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_